Hepatic and Renal Outcomes in Systemic Lupus Erythematosus Patients following Coronary Artery Bypass Grafting: A Study from the National Inpatient Sample
Table 3
Outcomes for systemic lupus erythematosus (SLE) patients compared to non-SLE patients after coronary artery bypass grafting (CABG) surgery.
Outcome
SLE patients n = 880
Non-SLE patients n = 322,226
OR (95% CI)
value
% (n)
% (n)
Death
3.3 (29)
2.4 (7,787)
0.92 (0.63–1.35)
0.671
Acute kidney injury
20.9 (184)
16.9 (54,543)
1.27 (1.06–1.53)
0.009
Acute myocardial infarction
46.5 (409)
44.5 (143,476)
0.94 (0.82–1.09)
0.413
Transient ischemic attack/stroke
5.9 (52)
5.6 (17,925)
0.98 (0.74–1.31)
0.903
Percutaneous coronary intervention
2.7 (24)
2.9 (9,205)
0.83 (0.55–1.25)
0.378
Mechanical circulatory support
10.8 (95)
9.6 (30,908)
0.91 (0.73–1.14)
0.408
Hemodialysis
16.9 (149)
12.6 (40,662)
1.16 (0.94–1.44)
0.166
Infections (defined as septicemia/septic shock, postoperative infection, central venous catheter-related infection, transfusion-related infection, or cardiac device-related infection)
4.0 (35)
2.8 (9,024)
1.02 (0.71–1.45)
0.931
Cardiogenic shock
6.3 (55)
5.9 (19,121)
0.76 (0.57–1.02)
0.072
Acute liver injury
0.91 (8)
1.3 (4,110)
0.36 (0.16–0.80)
0.012
Acute limb ischemia
0.34 (3)
0.27 (886)
0.75 (0.17–3.38)
0.713
OR: odds ratio, CI: confidence interval. The bold values indicate that p < 0.05.
